Sonnet Biotherapeutics Holdings Inc (SONN)

Finanzdaten der Sonnet Biotherapeutics Holdings Inc-Aktie (SONN)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	0.0186	0.0373	0.0369	0.0364
Operating Expenses	198.16% 3.8686	1.2975	3.6374	3.9522	5.7012
Benefits Costs and Expenses	0.8217	-	-	-	-
Costs And Expenses	198.16% 3.8686	1.2975	3.6374	3.9522	5.7012
Operating Income/Loss	202.50% -3.8686	-1.2789	-3.6001	-3.9153	-5.6648
Income/Loss From Continuing Operations Before Tax	131.27% 0.3654	-1.1685	0.0373	0.0369	-5.6671
Income/Loss From Continuing Operations After Tax	131.27% 0.3654	-1.1685	-3.6767	-3.9467	-5.6671
Net Income/Loss	131.27% 0.3654	-1.1685	-3.6767	-3.9467	-5.6671
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	21.59% 4.6177	3.7978	-16.53	29.38	16.51
Diluted Average Shares	28.65% 4.8858	3.7978	-16.53	29.38	-
Basic Earnings Per Share	125.81% 0.08	-0.31	-17.28	-0.13	-0.34
Diluted Earnings Per Share	122.58% 0.07	-0.31	-17.28	-0.13	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-